project id: TCGA-GBM; case submitter id: TCGA-74-6577; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; spectrophotometer method: UV Spec; age at index: 51; days to birth: -18740; ethnicity: not reported; gender: male; race: not reported; vital status: Alive; year of birth: 1959; age at diagnosis: 18740; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 132.0; icd 10 code: C71.9; last known disease status: not reported; morphology: 9440/3; primary diagnosis: Glioblastoma; prior malignancy: not reported; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Brain, NOS; synchronous malignancy: Not Reported; tissue or organ of origin: Brain, NOS; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; intermediate dimension: 0.9; longest dimension: 1.7; preservation method: Unknown; shortest dimension: 0.6; sample id: 32198a2b-9205-475f-aebd-a3714a7c0f9b; sample submitter id: TCGA-74-6577-01A; portion id: 876589ea-6d84-4b8a-91b9-9140c2c3125e; portion submitter id: TCGA-74-6577-01A-11; slide id: 86561028-d1c6-4548-bcef-97d2a9fe29a2; slide submitter id: TCGA-74-6577-01A-01-TS1; percent necrosis: 45.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 55.0; percent tumor nuclei: 75.0; section location: TOP;